Neuralink's Breakthrough in ALS Communication: Restoring Voice Through AI-Powered Brain-Computer Interface

Reportedly, on June 9, a case shared by Elon Musk on social media garnered global attention: his brain-computer interface company, Neuralink, successfully helped ALS patient Bradford Smith regain the ability to “speak” through technological integration with the AI company xAI. This breakthrough not only marks significant progress in brain-computer interface technology within the field of medical rehabilitation but also reveals the revolutionary potential brought about by the deep convergence of AI and neuroscience.

AI Voice Reproduction

After losing his mobility and speech due to amyotrophic lateral sclerosis (ALS), Smith opted to implant a brain-computer interface device developed by Neuralink. The cylindrical device, with a volume equivalent to just five stacked coins, captures neural signals via ultra-fine electrode threads implanted in the motor cortex of the brain and transmits them to a computer via Bluetooth. Unlike earlier devices, the core of this technological iteration lies in the integration of Grok, an artificial intelligence application from xAI. By combining Grok with audio and video footage of Smith recorded before his illness, a personalized AI voice model was trained. This model can complete sentences expressing the patient’s intent in real time and restore speech using his original voice, thereby enabling “thought-based conversation.”

Behind this breakthrough lies a dual upgrade in both hardware and algorithms by Neuralink. On the hardware front, the second-generation device has increased its electrode count to 3,000, while the R1 implantation robot enables micron-level precision within 10 minutes, significantly reducing brain tissue damage. At the algorithmic level, a neural decoder based on Proximal Policy Optimization (PPO) has shortened calibration time from 45 minutes to just 5 minutes, paving the way for a future “plug-and-play” experience. Furthermore, Neuralink’s collaboration with xAI marks the first application of large AI models to speech reconstruction, overcoming the limitations of traditional brain-computer interfaces that could only output text or synthetic speech.

Accelerating the Transition from Laboratory to Clinical Practice

Neuralink’s achievements are not isolated incidents. In March 2025, the China Brain-Computer Interface Industry Alliance released its “Top Ten Innovative Achievements,” among which the “BeiNao No. 1” semi-invasive wireless brain-computer system completed one of the first human implants internationally, achieving Chinese language decoding for patients with amyotrophic lateral sclerosis (ALS) who had lost speech. Additionally, the Institute of Brain-like Intelligence at Fudan University developed a “three-in-one” skull-implantable device, through which flexible electrodes with a diameter of 1 millimeter were implanted via a 4-hour minimally invasive surgery, enabling patients to regain leg movement within 24 hours post-operation.

The Divergence and Convergence of Technological Pathways Have Become a Trend. Invasive technologies, represented by Neuralink, pursue high-precision signal acquisition but face challenges related to long-term stability and ethical controversies; semi-invasive technologies, such as "Beinao No. 1," balance signal quality with surgical risk, becoming the mainstream direction for clinical applications; non-invasive technologies, leveraging their safety advantages, are rapidly gaining popularity in the field of rehabilitation training. For instance, Zhentai Intelligence's brain-controlled intelligent rehabilitation robots have been deployed in over one hundred tertiary hospitals across China.

AI empowerment has further accelerated technological iteration. Shanghai Lingwei Yisi’s large-scale EEG model, LaBraM, leverages a neural spectral predictor to achieve performance in tasks such as emotion recognition that far surpasses traditional deep learning models. Shenzhen Zhongke Huayi’s non-invasive closed-loop temporal interference deep brain stimulation system integrates multimodal neuroimaging with AI algorithms to enable precise, non-invasive modulation of deep brain regions. These breakthroughs indicate that brain-computer interfaces are transitioning from “signal decoding” to “intelligent interaction.”

Medical Breakthroughs Coexist with Ethical Challenges

For patients with amyotrophic lateral sclerosis (ALS), stroke, and spinal cord injury, brain-computer interface (BCI) technology is redefining the possibilities of rehabilitation. Smith can not only control a computer with his thoughts to perform video editing but also communicate with family members using AI-assisted speech; patients at Beijing Tiantan Hospital have achieved thought-controlled movement through “Beinao No. 1,” speaking the words “I want to drink water” for the first time after surgery. Behind these cases lies the disruptive innovation of BCI technology in neural function replacement.

However, the rapid advancement of technology has also sparked ethical controversies. Issues such as privacy risks associated with brain data, the potential for technological monopolies to exacerbate social inequality, and unresolved challenges related to long-term signal degradation and biocompatibility remain pressing concerns. For instance, Neuralink’s first patient experienced performance fluctuations due to an 85% electrode detachment rate, which was subsequently mitigated through dynamic algorithmic adjustments. Furthermore, AI-based voice reconstruction technologies are susceptible to misuse, such as synthesizing fake voices for fraudulent purposes.

At the policy level, regulatory frameworks are being accelerated globally. China has designated brain-computer interfaces (BCIs) as a strategic emerging industry, with Beijing and Shanghai issuing special action plans; notably, the National Healthcare Security Administration has established independent billing codes for both invasive and non-invasive BCIs for the first time. Meanwhile, the U.S. Food and Drug Administration (FDA) is expediting technical approvals through its “Breakthrough Device” designation, while requiring companies to submit long-term safety data.

The Neuralink case reveals the dual mission of brain-computer interface (BCI) technology: a short-term focus on restoring “digital freedom” for paralyzed patients, and a long-term goal of achieving human-machine symbiosis. Elon Musk has stated that the team’s objective is to enable patients to communicate at speeds surpassing those of fast typists, with future exploration potentially extending to direct interaction between brain signals and Optimus robots.

The trend of technological convergence is becoming increasingly evident. The integration of brain-computer interfaces (BCIs) with virtual reality (VR) and augmented reality (AR) may give rise to immersive experiences characterized by “thought-based control,” while their linkage with smart home systems enables users to adjust room temperature and operate appliances using only their thoughts. More profoundly, BCIs may reshape human cognitive patterns; as the brain interacts directly with external devices, human memory, learning, and even consciousness itself may be redefined.

As Tao Hu, founder of NeuroXess, stated, “Brain-computer interfaces are not merely ‘repair tools’ in the medical field, but also ‘new organs’ for enhancing human capabilities.” In this revolution of human-computer interaction, the balance between technological breakthroughs and ethical prudence will become a key issue determining the future.

One-Click Triple Action: “Share,” “Like,” and “Watch”

Stay Ahead of Every Breakthrough in Brain-Computer Interface Technology